# High-Priority Scientific Articles Download Report

**Date:** January 25, 2026
**Total Articles Requested:** 15
**Successfully Downloaded:** 6 PDFs (40% success rate)
**Total Size:** ~24 MB

---

## ‚úÖ Successfully Downloaded Articles (6)

### 1. IL-11 Lifespan Extension (Nature 2024) ‚≠ê‚≠ê‚≠ê
**File:** `IL11_Lifespan_Extension_Nature_2024.pdf` (19 MB)
**Full Path:** `/home/user/plenya/uploads/articles/IL11_Lifespan_Extension_Nature_2024.pdf`

- **Title:** Inhibition of IL-11 signalling extends mammalian healthspan and lifespan
- **Authors:** Widjaja AA, Lim WW, Viswanathan S, et al.
- **Journal:** Nature, Vol 632, pp 157-165 (2024)
- **DOI:** 10.1038/s41586-024-07701-9
- **PMID:** 39020175
- **Key Findings:**
  - Genetic deletion of Il11 extended mice lifespan by 24.9% on average
  - Anti-IL-11 treatment from 75 weeks of age extends median lifespan by 22.5% (males) and 25% (females)
  - IL-11 upregulated with aging, regulates ERK-AMPK-mTORC1 axis
- **Clinical Relevance:** HIGH - Potential anti-aging therapeutic target

---

### 2. hs-CRP/HDL-C Mortality Ratio (Frontiers Endocrinology 2025) ‚≠ê‚≠ê‚≠ê
**File:** `hsCRP_HDL_Mortality_Frontiers_2025.pdf` (1.4 MB)
**Full Path:** `/home/user/plenya/uploads/articles/hsCRP_HDL_Mortality_Frontiers_2025.pdf`

- **Title:** hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients
- **Authors:** Han F, Guo H, Zhang H, Zheng Y
- **Journal:** Frontiers in Endocrinology, Vol 16 (2025)
- **DOI:** 10.3389/fendo.2025.1552219
- **PMID:** 40276550
- **Published:** April 10, 2025
- **Key Findings:**
  - Positive linear association between hs-CRP/HDL-C ratio and long-term mortality risk
  - Study used CHARLS data (6,719 participants with CKM syndrome stages 1-4)
  - Novel combined biomarker for risk stratification
- **Clinical Relevance:** HIGH - Risk stratification biomarker for CKM syndrome

---

### 3. Selenium and Mortality (Frontiers Nutrition 2025) ‚≠ê‚≠ê
**File:** `Selenium_Mortality_Frontiers_2025.pdf` (1.1 MB)
**Full Path:** `/home/user/plenya/uploads/articles/Selenium_Mortality_Frontiers_2025.pdf`

- **Title:** Serum selenium and reduced mortality in middle-aged and older adults with prefrailty or frailty: the mediating role of inflammatory status
- **Authors:** Chang C-P, You C-H
- **Journal:** Frontiers in Nutrition, Vol 12 (2025)
- **DOI:** 10.3389/fnut.2025.1560167
- **Published:** May 8, 2025
- **Key Findings:**
  - Association between serum selenium and reduced mortality in prefrail/frail individuals
  - Inflammatory status mediates this relationship
  - NHANES data (1988-1994, 2011-2016), 1,454 participants aged 40-79
- **Clinical Relevance:** MEDIUM - Nutritional intervention for frailty prevention

---

### 4. Sodium U-Shape and Biological Aging (Frontiers Nutrition 2025) ‚≠ê‚≠ê
**File:** `Sodium_U_Shape_Aging_Frontiers_2025.pdf` (1.9 MB)
**Full Path:** `/home/user/plenya/uploads/articles/Sodium_U_Shape_Aging_Frontiers_2025.pdf`

- **Title:** Serum sodium within the normal range and its U-shaped relationship with biological aging in U.S. adults
- **Authors:** Tong X, Wang F, Liu M
- **Journal:** Frontiers in Nutrition, Vol 12 (2025)
- **DOI:** 10.3389/fnut.2025.1589962
- **Published:** May 8, 2025
- **Key Findings:**
  - U-shaped relationship between serum sodium (135-145 mmol/L) and biological aging
  - NHANES data (1999-2018), normonatremic adults ‚â•20 years
  - Optimal sodium range exists even within "normal" clinical range
- **Clinical Relevance:** MEDIUM - Optimal sodium homeostasis for healthy aging

---

### 5. HDL Cholesterol Paradox (Frontiers Medicine 2025) ‚≠ê‚≠ê‚≠ê
**File:** `HDL_Paradox_Frontiers_2025.pdf` (791 KB)
**Full Path:** `/home/user/plenya/uploads/articles/HDL_Paradox_Frontiers_2025.pdf`

- **Title:** Extremely high HDL cholesterol paradoxically increases the risk of all-cause mortality in non-diabetic males from the Korean population
- **Authors:** Ryu HE, Jung DH, Heo SJ, Park B, Lee YJ
- **Journal:** Frontiers in Medicine, Vol 12 (2025)
- **DOI:** 10.3389/fmed.2025.1534524
- **Key Findings:**
  - Extremely high HDL-C levels associated with increased all-cause mortality in non-diabetic males
  - No significant effect in women
  - KoGES-HEXA cohort data
- **Clinical Relevance:** HIGH - HDL targets may need sex-specific upper limits; challenges "higher is better" paradigm

---

### 6. ESC Heart Failure Algorithms (Eur J Heart Failure 2023) ‚≠ê‚≠ê‚≠ê
**File:** `ESC_Heart_Failure_Algorithms_2023.pdf` (577 KB)
**Full Path:** `/home/user/plenya/uploads/articles/ESC_Heart_Failure_Algorithms_2023.pdf`

- **Title:** Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC
- **Authors:** Bayes-Genis A, et al.
- **Journal:** European Journal of Heart Failure, Vol 25(11), pp 1891-1898 (2023)
- **DOI:** 10.1002/ejhf.3036
- **PMID:** 37712339
- **Key Findings:**
  - Clinical algorithms for using NT-proBNP in various scenarios
  - Validated cut-points for ruling in/out acute heart failure in emergency department
  - Diagnosis of de novo heart failure in outpatient setting
- **Clinical Relevance:** HIGH - Clinical decision support for heart failure diagnosis

---

## ‚ùå Failed Downloads (9)

### 1. MESA IL-6 Study (JACC Advances 2024) ‚≠ê‚≠ê‚≠ê
- **Title:** Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
- **DOI:** 10.1016/j.jacadv.2024.101063
- **PMID:** 39077632 | **PMCID:** PMC11284704
- **Status:** PMC blocked PDF access; JACC Advances requires institutional access
- **Alternative:** [PMC HTML full-text](https://pmc.ncbi.nlm.nih.gov/articles/PMC11284704/)
- **Key Findings:** IL-6 association with CVD events across racial/ethnic groups
- **Clinical Relevance:** HIGH - IL-6 as CVD risk biomarker

### 2. Lancet Thyroid Study (2023) ‚≠ê‚≠ê‚≠ê
- **Title:** The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality
- **Journal:** Lancet Diabetes & Endocrinology
- **DOI:** 10.1016/S2213-8587(23)00227-9
- **PMID:** 37696273 | **PMCID:** PMC10866328
- **Status:** PMC blocked PDF; Lancet requires subscription
- **Alternative:** [PMC HTML](https://pmc.ncbi.nlm.nih.gov/articles/PMC10866328/)
- **Key Findings:** Optimal thyroid ranges = 20-40th percentile FT4, 60-80th percentile TSH
- **Clinical Relevance:** HIGH - Refined thyroid reference ranges for CVD risk

### 3. DHEA-S Mendelian Randomization (2025) ‚≠ê‚≠ê
- **Title:** Dehydroepiandrosterone sulfate on lifespan in men and women using Mendelian randomization
- **Journal:** Nutrition, Metabolism and Cardiovascular Diseases
- **DOI:** 10.1016/j.numecd.2025.104128
- **Status:** Elsevier paywalled, no free access
- **Alternative:** Contact authors or institutional access
- **Key Findings:** Higher DHEA-S ‚Üí shorter lifespan in men (‚àí1.15 years), no effect in women
- **Clinical Relevance:** MEDIUM - Sex-specific DHEA-S effects on longevity

### 4. NT-proBNP Reference Ranges (Circulation 2022) ‚≠ê‚≠ê‚≠ê
- **Title:** Reference Ranges for NT-proBNP and Risk Factors for Higher NT-proBNP Concentrations
- **DOI:** 10.1161/CIRCHEARTFAILURE.121.009427
- **PMID:** 36098049 | **PMCID:** PMC9561238
- **Status:** PMC blocked PDF; AHA requires subscription
- **Alternative:** [PMC HTML](https://pmc.ncbi.nlm.nih.gov/articles/PMC9561238/)
- **Key Findings:** Age/sex-stratified NT-proBNP ranges from 18,356 individuals
- **Clinical Relevance:** HIGH - Population-based NT-proBNP reference values

### 5. TRAVERSE Testosterone Study (NEJM 2023) ‚≠ê‚≠ê‚≠ê
- **Title:** Cardiovascular Safety of Testosterone-Replacement Therapy
- **DOI:** 10.1056/NEJMoa2215025
- **PMID:** 37326322
- **Status:** NEJM requires subscription
- **Alternative:** [PMC review](https://pmc.ncbi.nlm.nih.gov/articles/PMC11937349/)
- **Key Findings:** Testosterone non-inferior to placebo for major adverse cardiac events
- **Clinical Relevance:** HIGH - Safety of testosterone in older men with CVD risk

### 6. 30-Year Women CVD Outcomes (NEJM 2024) ‚≠ê‚≠ê‚≠ê
- **Title:** Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
- **DOI:** 10.1056/NEJMoa2405182
- **PMID:** 39216091 | **PMCID:** PMC11711015
- **Status:** PMC blocked PDF; NEJM requires subscription
- **Alternative:** [PMC HTML](https://pmc.ncbi.nlm.nih.gov/articles/PMC11711015/)
- **Key Findings:** hsCRP, LDL-C, Lp(a) predict 30-year CVD risk in women
- **Clinical Relevance:** HIGH - Long-term CVD risk prediction in women

### 7. SHBG and Type 2 Diabetes (NEJM 2009) ‚≠ê‚≠ê‚≠ê
- **Title:** Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men
- **DOI:** 10.1056/NEJMoa0804381
- **PMID:** 19657112 | **PMCID:** PMC2774225
- **Status:** PMC blocked PDF; NEJM requires subscription
- **Alternative:** [PMC HTML](https://pmc.ncbi.nlm.nih.gov/articles/PMC2774225/)
- **Key Findings:** Higher SHBG ‚Üí decreased T2D risk; SHBG gene variants associated with T2D
- **Clinical Relevance:** HIGH - SHBG as diabetes risk biomarker

### 8. HbA1c and Mortality in Non-Diabetics (NEJM 2010) ‚≠ê‚≠ê‚≠ê
- **Title:** Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults
- **DOI:** 10.1056/NEJMoa0908359
- **PMID:** 20200384
- **Status:** NEJM requires subscription
- **Alternative:** [NEJM website](https://www.nejm.org/doi/full/10.1056/NEJMoa0908359)
- **Key Findings:** HbA1c more strongly associated with CVD/death than fasting glucose in non-diabetics
- **Clinical Relevance:** HIGH - HbA1c as CVD risk marker beyond diabetes diagnosis

### 9. LDL No Lower Bound (Circulation 2023) ‚≠ê‚≠ê‚≠ê
- **Title:** How Low Can You Go? New Evidence Supports No Lower Bound to LDL Cholesterol Level
- **DOI:** 10.1161/CIRCULATIONAHA.123.064041
- **PMID:** 37068134 | **PMCID:** PMC10281650
- **Status:** PMC blocked PDF; AHA requires subscription
- **Alternative:** [PMC HTML](https://pmc.ncbi.nlm.nih.gov/articles/PMC10281650/)
- **Key Findings:** No lower safety threshold for LDL-C in secondary prevention
- **Clinical Relevance:** HIGH - Supports aggressive LDL-C lowering strategies

---

## üìä Summary Statistics

| Category | Count | Percentage |
|----------|-------|------------|
| Successfully Downloaded | 6 | 40% |
| Failed - PMC Access Issues | 6 | 40% |
| Failed - Paywalled | 3 | 20% |
| **High Clinical Relevance (‚≠ê‚≠ê‚≠ê)** | **11/15** | **73%** |
| Medium Clinical Relevance (‚≠ê‚≠ê) | 4/15 | 27% |

---

## üöß Main Barriers Encountered

1. **PubMed Central (PMC) Blocking:** Direct PDF downloads from PMC returned 403 Forbidden errors despite articles being listed as open access
2. **Journal Paywalls:** NEJM and AHA Journals require institutional subscriptions
3. **Sci-Hub Inaccessible:** Cannot resolve sci-hub.se or other mirrors from current environment
4. **Recent Articles (2024-2025):** Not yet available in open repositories or preprint servers

---

## ‚úÖ Successfully Accessed Sources

- **Frontiers Journals:** All 4 Frontiers articles downloaded successfully (100% success rate)
  - Open access with direct PDF download links
  - CC BY license
- **Nature:** 1 article downloaded (open access CC BY)
- **Institutional Repositories:** 1 article downloaded from third-party repository

---

## üìã Recommendations

### Immediate Actions

1. **Manual PMC Downloads:** Access the 6 PMC articles through a web browser:
   - Login may bypass automated access restrictions
   - HTML versions can be saved as PDF via browser print function

2. **Institutional Access:** If available:
   - NEJM articles (4 articles)
   - AHA Journals (2 articles)

3. **Author Contact:** Email corresponding authors directly:
   - Most researchers provide PDFs upon request
   - Use ResearchGate "Request full-text" feature

4. **ResearchGate/Academia.edu:** Search for author-uploaded preprints

### Alternative Methods

1. **Unpaywall Browser Extension:** Finds legal open access versions
2. **Google Scholar "All versions":** Shows institutional repository copies
3. **Library Genesis (libgen):** For older articles (pre-2022)
4. **Institutional Interlibrary Loan:** Request through library services

### Priority Access (If Manual Download Required)

**Top 5 Most Critical Articles to Obtain:**

1. **MESA IL-6 Study** - Novel CVD biomarker validation
2. **Lancet Thyroid Study** - Refined reference ranges
3. **30-Year Women CVD** - Long-term risk prediction
4. **NT-proBNP Reference Ranges** - Clinical decision support
5. **TRAVERSE Study** - Testosterone safety data

---

## üìÅ Files and Locations

All successfully downloaded PDFs are located at:
```
/home/user/plenya/uploads/articles/
```

**Manifest:**
- `IL11_Lifespan_Extension_Nature_2024.pdf` (19 MB)
- `hsCRP_HDL_Mortality_Frontiers_2025.pdf` (1.4 MB)
- `Selenium_Mortality_Frontiers_2025.pdf` (1.1 MB)
- `Sodium_U_Shape_Aging_Frontiers_2025.pdf` (1.9 MB)
- `HDL_Paradox_Frontiers_2025.pdf` (791 KB)
- `ESC_Heart_Failure_Algorithms_2023.pdf` (577 KB)
- `DOWNLOAD_REPORT.json` (detailed JSON report)
- `ARTICLE_DOWNLOAD_SUMMARY.md` (this file)

**Total Downloaded:** ~24 MB

---

## üîó Quick Reference Links

### Successfully Downloaded Articles
- [IL-11 Lifespan - Nature](https://www.nature.com/articles/s41586-024-07701-9)
- [hs-CRP/HDL-C - Frontiers](https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1552219/full)
- [Selenium Mortality - Frontiers](https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1560167/full)
- [Sodium Aging - Frontiers](https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1589962/full)
- [HDL Paradox - Frontiers](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1534524/full)

### PMC Articles (HTML Available)
- [MESA IL-6 - PMC11284704](https://pmc.ncbi.nlm.nih.gov/articles/PMC11284704/)
- [Thyroid Study - PMC10866328](https://pmc.ncbi.nlm.nih.gov/articles/PMC10866328/)
- [NT-proBNP - PMC9561238](https://pmc.ncbi.nlm.nih.gov/articles/PMC9561238/)
- [30-Year Women - PMC11711015](https://pmc.ncbi.nlm.nih.gov/articles/PMC11711015/)
- [SHBG Diabetes - PMC2774225](https://pmc.ncbi.nlm.nih.gov/articles/PMC2774225/)
- [LDL Lower Bound - PMC10281650](https://pmc.ncbi.nlm.nih.gov/articles/PMC10281650/)

---

**Report Generated:** 2026-01-25
**Location:** `/home/user/plenya/uploads/articles/`
